The study included 31 patients (57±14 years, 23 males) with HCM and preserved LVEF (65±8%, range 50 to 79%) without significant LV obstruction (<50mmHg) at rest. All underwent exercise testing and 2D and 3D echocardiography. LV dyssynchrony defined by the 16 segment standard deviation of time to peak longitudinal strain by speckle tracking (16SD) was compared to exercise capacity, 3D myocardial mass and LV filling pressure assessed by the ratio E/E' TDI (Peak early filling velocity over peak systolic velocity by TDI).
Conclusion:
Myocardial dyssynchrony increased with the severity of myocardial hypertrophy in HCM patients and may be involved in exercise limitation in patients without LV obstruction and preserved LVEF.
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VO2 max to measure the functional status of obese heart failure patients.
Joffrey Pozzo (1), Pauline Fournier (1), Olivier Lairez (1), Meyer Elbaz (1), Atul Pathak (1), Philippe Rouet (2), Michel Galinier (1), Jérome Roncalli (1) (1) CHU Rangueil, Pôle cardio-vasculaire et métabolique, Toulouse, France -(2) INSERM U858, Toulouse, France Background: Obesity has been described as an independent risk factor for heart failure (HF). However, B-type natriuretic peptide (BNP) failed in evaluation of the severity of HF in obese patient because: i) Obese patients suffer dyspnoea earlier than non obese which leads to an earlier diagnosis an could explain lower BNP rates, and ii) BNP receptors were found on adipocytes suggesting a higher clearance of BNP in obese patients.
Purpose: Our aim was to explore the relationship between functional status of obese HF patients and BNP levels.
Method and results:
In our HF registry, 249 patients with dilated cardiomyopathy (DCM) were included in 3 groups regarding their body mass index: 112 normal weighted <25 kg/m 2 (NW), 88 overweighted 25-29.9 kg/m 2 (OW), and 49 obese 30 kg/m 2 or greater (Ob) patients. We analyzed NYHA status, the 6 minutes walk test (6MWT) a simple and reliable way to assess the exercise capacity of DCM patients, and measured the peak oxygen consumption during incremental exercise (VO2 max).
There was no significant difference between the 3 groups for baseline characteristics and ejection fraction was comparable (NW: 27+/-9%; OW: 27+/-9%; Ob: 29+/-10%; p=0.26)) BNP levels were lower in the obese group (962+/-1166 in NW, 757+/-204 in OW, 353+/-608 in Ob; p=0.02). There was no significant difference between groups in distance covered in the 6MWT (NW: 370+/-98m; OW: 392+/-125m; Ob: 388m; p=0.27) and NYHA scores (NM: 2.3+/-0.7; OW: 2.3+/-0.6; Ob: 2.4+/-0.7; p=0.32), however, VO2 max was significantly lower in the Ob patients (NW: 17.4+/-7.7 ml/min/kg; OW: 16.1+/-5.0 ml/min/kg; Ob: 14.8+/-6.9ml/min/kg; p=0.04).
Conclusion:
These results show that VO2 max is more useful to discriminate functional status in obese patients with DCM compared to 6MWT, NYHA scores and BNP levels. BNP in the obese likely underestimates severity of HF.
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Ability of ST/HR index and ST/HR hysteresis during exercise testing to predict significant ischemia assessed by G-SPECT imaging
Cyril Cohen (1), Silviu Stanciu (2), Gerald Roul (1), Christian Goetz (3), Mc Perier (1), Andre Constantinesco (3) (1) University Hospitals, Cardiology, Strasbourg, France -(2) University Military Hospital, Internal Medicine -Cardiologie, Bucarest, Roumanie -(3) University Hospitals, Nuclear Medicine, Strasbourg, France Introduction: Heart failure (HF) remains a frequent reason for admission and readmission to hospital and therefore represents a major public health burden. The aim of our study is to report the experience of our therapeutic unit of heart failure (TUHF), the epidemiological profile, the management and the outcome of 1200 patients with chronic heart failure (CHF).
Material and methods:
The study included 1200 patients, admitted in the TUHF from May 2006 to February 2010. We included all patients with (CHF) symptomatic class II, III, or IV. All patients were evaluated clinically with monitoring of blood pressure , 6 min walk test and electrocardiogram. Twodimensional echocardiography and laboratory tests were performed in all patients.
Results:
The mean age of our patients was 64.82±12.14 years (16-100), 75% were men. Hypertension was the most frequently cardiovascular risk factor (26%) followed by smoking (22%) and diabetes (21%). Patients were mainly in NYHA class II ( 58%), and 27% were in NYHA class III. The average of 6 minute walk test was 121.36 ±92.74 m (10 -630 ). The mean heart rate at admission was 81.13 ± 17.24 bpm. More than half of our patients had an LVEF <35% (56.91%), 31.33% had LVEF between 35-50%, and 6.33% had an LVEF> 50%. Ischemic (55.67%) and hypertensive heart disease (2.67%) remain the two most frequent etiology. Regarding treatment; 78.33% of our patients were treated with beta-blockers, 89.08%with Angiotensin-converting enzyme inhibitors (ACEI), 50.75% with spironolactone , and 12.75% with diuretics. Resynchronization has been performed in two patients. The optimal medical treatment has allowed a significant improvement in NYHA functional class: NYHA class II (20% vs. 58%, P= 0.037), NYHA class III (5% vs 27%, P= 0.002), a significant improvement in test 6min walk ( 121.36 vs 465.66 m, P= 0.0001), and a significant reduction in heart rate from 80.13 bpm to 63.12bpm (P< 0.05) on an average of 6.82± 4.18 months.
Conclusion:
The creating of TUHF in our department has allowed an improving of the quality of care and an optimization of the treatment.
